3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Withdrawn
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Plasma cell
1
Conditions
Breast Neoplasms
8
Small Cell Lung Carcinoma
4
Colorectal Neoplasms
4
Rectal Neoplasms
3
Prostatic Neoplasms
2
Neoplasm Metastasis
2
Multiple Myeloma
2
Colonic Neoplasms
2
Carcinoma, Intraductal, Noninfiltrating
2
Breast Carcinoma In Situ
2
Waldenstrom Macroglobulinemia
1
Urinary Bladder Neoplasms
1
Triple Negative Breast Neoplasms
1
Smoldering Multiple Myeloma
1
Pancreatic Neoplasms
1
Neoplasms, Plasma Cell
1
Margins of Excision
1
Lung Neoplasms
1
Leiomyoma
1
Fibrosis
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Hepatocellular
1
Brain Neoplasms
1
Biliary Tract Neoplasms
1
Interventions
Dexamethasone
11
Lenalidomide
9
Calcium Dobesilate
5
carfilzomib
4
daratumumab
3
isatuximab
2
iberdomide
2
elotuzumab
2
dexamethasone acetate
2
dexamethasone 21-phosphate
2
auricularum
2
Leflunomide
2
Denosumab
2
selinexor
1
pomalidomide
1
piperine
1
ixazomib
1
ibrutinib
1
fludarabine phosphate
1
fludarabine
1
Simvastatin
1
Nivolumab
1
Metformin
1
Melphalan
1
IPH-2101
1
Gene Expression Profiling
1
Fatty Acids, Omega-3
1
Cyclophosphamide
1
Curcumin
1
Cholestyramine Resin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Smoldering Multiple Myeloma
×
Simvastatin
×
Clear all
NCT00503763
2015-04-16
PSMMSS
Meir Medical Center
Phase 2
Withdrawn